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P U B L I S H E D B Y E L S E V I E R I N C .LettersFinding ECG Readers
in Clinical Practice
Is It Time to Change the Paradigm?The standard 12-lead electrocardiogram (ECG) is the
most commonly performed cardiac diagnostic test
because it provides vital information about cardiac
rhythm, acute myocardial injury, and a host of
other abnormalities while also being simple to per-
form, risk free, and inexpensive. Historically, ECG
readers have been trained in cardiology and clinical
electrocardiography. However, mentoring of cardi-
ology trainees in clinical electrocardiography has
been superseded by a host of emerging diagnostic
and treatment modalities such as invasive pro-
cedures, imaging techniques, cardiac device thera-
pies, and cardiogenomics. As a result, there is an
ever-shrinking pool of cardiologists who have the
expertise or desire to read ECGs. In the United States,
most ECGs are read by noncardiologists (emergency,
internal-medicine, and family-practice physicians)
who have had minimal training in clinical electro-
cardiography (1). Inadequate training of ECG readers
has also led to an overreliance on computerized
measurements/interpretations that are frequently
inaccurate.
In some hospitals, there is already an inadequate
supply of ECG readers, and the problem is made worse
by minimal reimbursement from payers. The small
professional fee to a physician for reading an ECG
(about $9.00 in the San Francisco area) has forced some
hospitals to augment the professional fee at the hos-
pital’s expense in order to ﬁnd enough readers for the
large volume of ECGs generated each day.
The relevant question is whether it is time to
consider training and certifying cardiovascular nurse
practitioners to read ECGs, thereby supplementing
the shrinking pool of expert ECG readers. Cardiolo-
gists have confronted similar challenges in the past.
For example, at the initiation of coronary care units,
cardiologists delegated arrhythmia interpretation to
specially trained coronary care unit nurses (2,3). We
believe that it is time to consider training and certi-
fying nurse practitioners specializing in cardiology
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1886–93.Effect of Spironolactone
in CV Mortality
in Hemodialysis PatientsMatsumoto et al. (1) have investigated the role of
spironolactone in hemodialysis patients. The in-
vestigators have noted that spironolactone reduced
the risk of both cardiovascular morbidity and mor-
tality in hemodialysis patients. It would be inter-
esting to know the left ventricular mass index and left
ventricular ejection fraction in the study population
because these 2 parameters have been demonstrated
to be objective variables predictive of adverse car-
diovascular outcomes in patients with end-stage
renal disease (ESRD). The improved cardiovascular
outcomes could have been due to an improvement
in the aforementioned parameters (2). It would also
